QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
NASDAQ:GRTX

Galera Therapeutics (GRTX) News Today

$3.13
-0.03 (-0.95%)
(As of 06/5/2023 ET)
Compare
Today's Range
$3.07
▼
$3.18
50-Day Range
$2.44
▼
$3.34
52-Week Range
$1.12
▼
$3.50
Volume
393,564 shs
Average Volume
609,147 shs
Market Capitalization
$134.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.75
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
Get Galera Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRTX and its competitors with MarketBeat's FREE daily newsletter.



GRTX Media Mentions By Week

GRTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GRTX
News Sentiment
▼
0.00

0.56
▲
Average
Medical
News Sentiment

GRTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GRTX Articles
This Week
▼
0

1
▲
GRTX Articles
Average Week

SourceHeadline
finance.yahoo.com logoGalera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual Meeting
finance.yahoo.com - June 5 at 6:57 PM
finance.yahoo.com logoGalera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer
finance.yahoo.com - May 18 at 10:13 AM
finance.yahoo.com logoGalera Therapeutics, Inc.'s (NASDAQ:GRTX) largest shareholders are retail investors with 45% ownership, institutions own 34%
finance.yahoo.com - May 18 at 10:13 AM
finanznachrichten.de logoGalera Therapeutics: Galera Reports First Quarter 2023 Financial Results and Recent Corporate Updates
finanznachrichten.de - May 11 at 10:31 AM
finance.yahoo.com logoGalera Reports First Quarter 2023 Financial Results and Recent Corporate Updates
finance.yahoo.com - May 11 at 10:31 AM
finance.yahoo.com logoGalera Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - May 4 at 7:37 PM
finance.yahoo.com logoGalera Expands Commercial Leadership Team
finance.yahoo.com - May 1 at 8:14 AM
finance.yahoo.com logoGalera to Present One-Year Reductions in Cisplatin-Related Chronic Kidney Disease Data from ROMAN Trial at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
finance.yahoo.com - April 26 at 10:29 AM
MarketBeat logoGalera Therapeutics, Inc. (NASDAQ:GRTX) to Post Q1 2023 Earnings of ($0.31) Per Share, HC Wainwright Forecasts
americanbankingnews.com - March 26 at 1:20 AM
MarketBeat logoHC Wainwright Comments on Galera Therapeutics, Inc.'s FY2024 Earnings (NASDAQ:GRTX)
americanbankingnews.com - March 25 at 2:48 AM
MarketBeat logoGalera Therapeutics, Inc. Forecasted to Earn FY2024 Earnings of ($0.66) Per Share (NASDAQ:GRTX)
americanbankingnews.com - March 25 at 2:48 AM
MarketBeat logoGalera Therapeutics (NASDAQ:GRTX) Price Target Cut to $6.00
americanbankingnews.com - March 24 at 5:16 AM
benzinga.com logoGalera Therapeutics Stock (NASDAQ:GRTX), Analyst Ratings, Price Targets, Predictions
benzinga.com - March 23 at 6:57 AM
MarketBeat logoHC Wainwright Trims Galera Therapeutics (NASDAQ:GRTX) Target Price to $6.00
americanbankingnews.com - March 23 at 5:40 AM
markets.businessinsider.com logoAnalyst Ratings for Galera Therapeutics
markets.businessinsider.com - March 22 at 12:33 PM
markets.businessinsider.com logoWhere Galera Therapeutics Stands With Analysts
markets.businessinsider.com - March 22 at 12:33 PM
markets.businessinsider.com logoH.C. Wainwright Reaffirms Their Buy Rating on Galera Therapeutics (GRTX)
markets.businessinsider.com - March 22 at 7:32 AM
MarketBeat logoInsider Buying: Galera Therapeutics, Inc. (NASDAQ:GRTX) Insider Acquires 11,000 Shares of Stock
americanbankingnews.com - March 22 at 4:54 AM
finance.yahoo.com logoGalera Announces Presentation of Supplemental Analysis of Phase 3 ROMAN Trial at European Congress on Head and Neck Oncology
finance.yahoo.com - March 10 at 9:41 AM
finance.yahoo.com logoThese 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts
finance.yahoo.com - March 8 at 5:33 PM
finanznachrichten.de logoGalera Therapeutics: Galera Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates
finanznachrichten.de - March 8 at 9:52 AM
finance.yahoo.com logoGalera Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates
finance.yahoo.com - March 8 at 9:52 AM
benzinga.com logoGalera Therapeutics Chief Financial Officer Awarded $331K Worth of Stock Options
benzinga.com - March 2 at 1:02 PM
benzinga.com logoGalera Therapeutics Chief Operating Officer Awarded $241K Worth of Stock Options
benzinga.com - March 1 at 3:43 PM
benzinga.com logoPresident and CEO at Galera Therapeutics Acquires Company Stock Options Worth 440,000 Shares
benzinga.com - March 1 at 10:42 AM
benzinga.com logoGalera Therapeutics Chief Commercial Officer Awarded $241K Worth of Stock Options
benzinga.com - March 1 at 10:42 AM
247wallst.com logoPiper Sandler Initiates Coverage of Galera Therapeutics With Overweight Recommendation
247wallst.com - February 23 at 11:46 PM
finance.yahoo.com logoGalera Therapeutics expects to raise $30M from direct stock offering
finance.yahoo.com - February 15 at 3:31 PM
marketwatch.com logoGalera Therapeutics Shares Rise Premarket on FDA Priority Review >GRTX
marketwatch.com - February 15 at 10:31 AM
finance.yahoo.com logoGalera Announces FDA Acceptance and Priority Review of Avasopasem NDA for Radiotherapy-Induced Severe Oral Mucositis
finance.yahoo.com - February 15 at 10:31 AM
finance.yahoo.com logoGalera Therapeutics Announces Pricing of Registered Direct Offering of $30 Million of Common Stock and Warrants
finance.yahoo.com - February 15 at 10:31 AM
finance.yahoo.com logoMalvern-based Galera shares rise on FDA filing for lead cancer therapy drug
finance.yahoo.com - December 12 at 4:59 PM
finance.yahoo.com logoGalera Submits New Drug Application for Avasopasem for Severe Oral Mucositis
finance.yahoo.com - December 12 at 7:54 AM
finance.yahoo.com logoGalera to Present at Piper Sandler Annual Healthcare Conference
finance.yahoo.com - November 22 at 7:15 PM
finanznachrichten.de logoGalera Therapeutics: Galera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
finanznachrichten.de - November 9 at 9:36 AM
finance.yahoo.com logoGalera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
finance.yahoo.com - November 9 at 9:36 AM
finance.yahoo.com logoOne Galera Therapeutics, Inc. (NASDAQ:GRTX) insider upped their stake by 50% in the previous year
finance.yahoo.com - November 7 at 7:28 PM
finance.yahoo.com logoGalera Therapeutics' Avasopasem Reduces Chemo-Related Kidney Disease By 50% Versus Placebo At One-Year
finance.yahoo.com - November 1 at 12:50 PM
finance.yahoo.com logoGalera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
finance.yahoo.com - October 26 at 3:14 PM
finance.yahoo.com logoGalera to Present at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
finance.yahoo.com - September 26 at 8:24 AM
nasdaq.com logoCompanies Like Galera Therapeutics (NASDAQ:GRTX) Could Be Quite Risky
nasdaq.com - September 21 at 8:56 AM
finance.yahoo.com logoGalera to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
finance.yahoo.com - September 6 at 11:59 AM
finance.yahoo.com logoHere's Why Galera Therapeutics (NASDAQ:GRTX) Must Use Its Cash Wisely
finance.yahoo.com - August 29 at 12:10 PM
seekingalpha.com logoGalera Therapeutics (GRTX) Investor Presentation - Slideshow
seekingalpha.com - August 16 at 10:36 AM
msn.com logoRecap: Galera Therapeutics Q2 Earnings
msn.com - August 9 at 11:30 AM
seekingalpha.com logoGalera down ~8% after phase 1 data for non-small cell lung cancer combination treatment
seekingalpha.com - June 29 at 3:38 PM
finance.yahoo.com logoGalera Therapeutics' Rucosopasem Shows Early Anti-Cancer Activity, Pulmonary Function Preservation
finance.yahoo.com - June 29 at 3:38 PM
finance.yahoo.com logoGalera Announces Results from Phase 1 Stage of GRECO-1 Trial of Rucosopasem with SBRT for NSCLC
finance.yahoo.com - June 29 at 10:37 AM
finance.yahoo.com logoGalera to Present at Jefferies Healthcare Conference
finance.yahoo.com - June 2 at 10:16 AM
finance.yahoo.com logoMultiple insiders bought Galera Therapeutics, Inc. (NASDAQ:GRTX) stock earlier this year, a positive sign for shareholders
finance.yahoo.com - May 30 at 2:50 PM
Get Galera Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:GRTX) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -